Pfizer sues Novo, Metsera
Digest more
Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...
Novo Nordisk's new CEO, Mike Doustdar, is under significant pressure as the company contends with declining stock prices, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results